Yamo Pharmaceuticals Alternatives & Competitors
12 companies similar to Yamo Pharmaceuticals — Yamo Pharmaceuticals is developing L1-79, a novel therapy that targets the core...
Companies similar to Yamo Pharmaceuticals
Proniras Corporation
Clinical-stage biotechnology developing therapeutics for the treatment of substance use &...
Seattle, United States
Lytix Biopharma
A clinical-stage immuno-oncology company developing proprietary oncolytic drugs as a novel...
Oslo, Norway
Pacylex Pharmaceuticals, Inc.
A new target in cancer care - triggering selective lethality with a new class of drugs.
Edmonton, Canada
Reviva Pharmaceuticals
Next Generation Therapeutics to successfully address central nervous system, metabolic and...
Cupertino, United States
Track all Yamo Pharmaceuticals competitors
Get real-time alerts when any of these companies raise funding, hire, or show growth signals.
Relmada Therapeutics, Inc
Relmada (Nasdaq: $RLMD) is a clinical-stage company developing novel therapies for the tre...
Coral Gables, United Stat...
Prescient Therapeutics
A clinical stage oncology company developing personalised medicine approaches to cancer; c...
Australia
Genprex, Inc.
Genprex is a gene therapy company focused on developing life-changing technologies for pat...
Austin, United States
OliX Pharmaceuticals, Inc.
Contributing to the Health and Happiness of Mankind with RNAi Technology
Korea South
Cinclus Pharma
Developing effective treatment for gastric acid related diseases.
Stockholm, Sweden
Chemomab Therapeutics
Developing innovative therapeutics for diseases at confluence of fibrosis and inflammation...
Israel
Topica Pharmaceuticals
Developing the first highly effective and safe topical therapy for onychomycosis.
Cambridge, United States
About Yamo Pharmaceuticals
Yamo Pharmaceuticals, founded in 2015 and headquartered in the United States, is gaining attention in the biotechnology and pharmaceutical industries. The company's mission, as summarized in its slogan, is to develop innovative therapies that address core symptoms of autism. Yamo Pharmaceuticals' flagship product, L1-7...
Yamo Pharmaceuticals, L1-79, Novel Therapy, Autism, Clinical-stage Pharmaceutical Company, Drug Development, Life Sciences, ASD, Biopharmaceuticals
Frequently Asked Questions
Don't just read about them. Follow them.
BounceWatch watches Yamo Pharmaceuticals and millions of other companies. When one raises money, hires quickly or changes its product, we tell you the same day.
Compiled from the BounceWatch company index. We last looked at Yamo Pharmaceuticals on 12 Sep 2024. The 12 companies listed here were last checked between 11 Sep 2024 and 6 Dec 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
